Tag Archive: Discoveries, Fostera Gold PCV MH, Meggan Bandrick
PCV2 vaccine for swine elicits strong cell-mediated immune response
Aug 26, 2021Jennifer GrullonComments Off on PCV2 vaccine for swine elicits strong cell-mediated immune response
DISCOVERIES, Issue 9: A porcine circovirus type 2 (PCV2) vaccine from Zoetis produces a robust and lasting cell-mediated immune response.High prevalence of PCV2 recombinants highlights importance of broad vaccine coverage
May 22, 2021Jennifer GrullonComments Off on High prevalence of PCV2 recombinants highlights importance of broad vaccine coverage
DISCOVERIES, Issue 21: A recent analysis of porcine circovirus type 2 (PCV2) genetic sequences shows that up to 25% of field strains are recombinants of diverse genotypes, highlighting the importance...Rate of PCV2 recombination not widely recognized
May 15, 2021Jennifer GrullonComments Off on Rate of PCV2 recombination not widely recognized
TOOLBOX, Issue 16: An interview with Meggan Bandrick, DVM, PhD Associate Director, Global Biologics Research, ZoetisEvolution of PCV2 virus, need for broader coverage spurred development of Fostera® Gold PCV MH
Mar 01, 2019Jennifer GrullonComments Off on Evolution of PCV2 virus, need for broader coverage spurred development of Fostera® Gold PCV MH
DISCOVERIES, Issue 7: Compelling scientific evidence indicating the need for an updated porcine circovirus type 2 (PCV2) vaccine was the driving force behind the development of Fostera® Gold PCV...Scientist ‘pops the hood’ on US pork industry’s newest vaccine for PCV2
Nov 28, 2018Jennifer GrullonComments Off on Scientist ‘pops the hood’ on US pork industry’s newest vaccine for PCV2
What is “cell-mediated immunity” and how does it affect vaccine performance? Are two PCV2 genotypes necessarily better than one? And what does a monster from Greek mythology have to do with...Part 1: Cell-mediated immunity critical to vaccine performance
Nov 28, 2018Jennifer GrullonComments Off on Part 1: Cell-mediated immunity critical to vaccine performance
What is “cell-mediated immunity” and how does it affect vaccine performance? Are two PCV2 genotypes necessarily better than one? And what does a monster from Greek mythology have to do with...Part 2: Why two PCV2 genotypes are better than one
Nov 28, 2018Jennifer GrullonComments Off on Part 2: Why two PCV2 genotypes are better than one
What is “cell-mediated immunity” and how does it affect vaccine performance? Are two PCV2 genotypes necessarily better than one? And what does a monster from Greek mythology have to do with...Part 3: Chimeric vaccines combine strengths of each antigen to provide better coverage
Nov 28, 2018Jennifer GrullonComments Off on Part 3: Chimeric vaccines combine strengths of each antigen to provide better coverage
What is “cell-mediated immunity” and how does it affect vaccine performance? Are two PCV2 genotypes necessarily better than one? And what does a monster from Greek mythology have to do with...Epitope-comparison study illustrates broad coverage of Fostera Gold® PCV MH against PCV2 viruses
Aug 15, 2018Jennifer GrullonComments Off on Epitope-comparison study illustrates broad coverage of Fostera Gold® PCV MH against PCV2 viruses
DISCOVERIES, Issue 4: Swine disease specialists speculated that a PCV2 vaccine containing two genotypes — PCV2a and PCV2b — would significantly improve the coverage provided against PCV2...